Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 138.49
+6.59 (5.00%)
Jun 1, 2026, 1:52 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 3.28 billion as of June 1, 2026. Its market cap has increased by 90.76% in one year.
Market Cap
3.28B
Enterprise Value
3.63B
Revenue
1.55B
Ranking
n/a
PE Ratio
29.53
Stock Price
138.49
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 3.28B, an increase of 30,006.52%. That is a compound annual growth rate of 149.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 3.28B | -8.11% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 14.43B |
| Jagsonpal Pharmaceuticals | 13.87B |
| Ind-Swift Laboratories | 13.19B |
| Sigachi Industries | 8.14B |
| Valiant Laboratories | 4.21B |
| Nectar Lifesciences | 2.42B |
| Brooks Laboratories | 1.92B |
| Alpa Laboratories | 1.50B |